Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1979 Dec;26(3):795–801. doi: 10.1128/iai.26.3.795-801.1979

Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations.

R J Avery, J Niven
PMCID: PMC414688  PMID: 528055

Abstract

The H/N and F1 glycoproteins responsible for hemagglutinin/neuraminidase (H/N) activity and fusion (F1) activity were purified from several Newcastle disease virus strains and used to produce antisera. These antisera can be used to clearly distinguish the virus strains by a number of techniques including radioimmunoassay, and so provide a means of classifying new virus isolates. The variations detected between strains are not related to field virulence.

Full text

PDF
795

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan W. H. The problem of Newcastle disease. Nature. 1971 Nov 19;234(5325):129–131. doi: 10.1038/234129a0. [DOI] [PubMed] [Google Scholar]
  2. Avery R. J. Abortive infection of L cells by influenza virus: absence of virion RNA synthesis. J Virol. 1975 Aug;16(2):311–314. doi: 10.1128/jvi.16.2.311-314.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen C., Compans R. W., Choppin P. W. Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol. 1971 Apr;11(1):53–58. doi: 10.1099/0022-1317-11-1-53. [DOI] [PubMed] [Google Scholar]
  4. GRANOFF A. Studies on mixed infection with Newcastle disease virus. I. Isolation of Newcastle disease virus mutants and tests for genetic recombination between them. Virology. 1959 Dec;9:636–648. doi: 10.1016/0042-6822(59)90154-0. [DOI] [PubMed] [Google Scholar]
  5. Garlick B., Avery R. J. Inactivation of Newcastle disease virus by beta-propiolactone. Arch Virol. 1976;52(1-2):175–179. doi: 10.1007/BF01317878. [DOI] [PubMed] [Google Scholar]
  6. HANSON R. P., BRANDLY C. A. Identification of vaccine strains of Newcastle disease virus. Science. 1955 Jul 22;122(3160):156–157. [PubMed] [Google Scholar]
  7. MACPHERSON L. W., SWAIN R. H. Strain differences in the Newcastle disease virus. J Hyg (Lond) 1956 Jun;54(2):234–245. doi: 10.1017/s0022172400044491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Moore N. F., Burke D. C. Characterization of the structural proteins of different strains of Newcastle disease virus. J Gen Virol. 1974 Nov;25(2):275–289. doi: 10.1099/0022-1317-25-2-275. [DOI] [PubMed] [Google Scholar]
  9. Nagai Y., Klenk H. D., Rott R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology. 1976 Jul 15;72(2):494–508. doi: 10.1016/0042-6822(76)90178-1. [DOI] [PubMed] [Google Scholar]
  10. Orvell C., Norrby E. Immunologic properties of purified Sendai virus glycoproteins. J Immunol. 1977 Dec;119(6):1882–1887. [PubMed] [Google Scholar]
  11. Parks W. P., Scolnick E. M. Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1766–1770. doi: 10.1073/pnas.69.7.1766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pennington T. H. Antigenic differences between strains of Newcastle disease virus. Arch Virol. 1978;56(4):345–351. doi: 10.1007/BF01315286. [DOI] [PubMed] [Google Scholar]
  13. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology. 1972 Dec;50(3):640–652. doi: 10.1016/0042-6822(72)90418-7. [DOI] [PubMed] [Google Scholar]
  14. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 1974 Feb;57(2):475–490. doi: 10.1016/0042-6822(74)90187-1. [DOI] [PubMed] [Google Scholar]
  15. Scheid A., Choppin P. W. Isolation and purification of the envelope proteins of Newcastle disease virus. J Virol. 1973 Feb;11(2):263–271. doi: 10.1128/jvi.11.2.263-271.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Scheid A., Choppin P. W. The hemagglutinating and neuraminidase protein of a paramyxovirus: interaction with neuraminic acid in affinity chromatography. Virology. 1974 Nov;62(1):125–133. doi: 10.1016/0042-6822(74)90308-0. [DOI] [PubMed] [Google Scholar]
  17. Schloer G., Spalatin J., Hanson R. P. Newcastle disease virus antigens and strain variations. Am J Vet Res. 1975 Apr;36(4 Pt 2):505–508. [PubMed] [Google Scholar]
  18. Seto J. T., Becht H., Rott R. Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus. Virology. 1974 Oct;61(2):354–360. doi: 10.1016/0042-6822(74)90273-6. [DOI] [PubMed] [Google Scholar]
  19. Shimizu K., Shimizu Y. K., Koama T., Ishida N. Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes. Virology. 1974 Nov;62(1):90–101. doi: 10.1016/0042-6822(74)90305-5. [DOI] [PubMed] [Google Scholar]
  20. Tozawa H., Watanabe M., Ishida N. Structural components of Sendai virus. Serological and physicochemical characterization of hemagglutinin subunit associated with neuraminidase activity. Virology. 1973 Sep;55(1):242–253. doi: 10.1016/s0042-6822(73)81027-x. [DOI] [PubMed] [Google Scholar]
  21. UPTON E., HANSON R. P., BRANDLY C. A. Antigenic differences among strains of Newcastle disease virus. Proc Soc Exp Biol Med. 1953 Dec;84(3):691–693. doi: 10.3181/00379727-84-20754. [DOI] [PubMed] [Google Scholar]
  22. Waterson A. P., Pennington T. H., Allan W. H. Virulence in Newcastle disease virus. A preliminary study. Br Med Bull. 1967 May;23(2):138–143. doi: 10.1093/oxfordjournals.bmb.a070534. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES